Kling Douglas F — SEC Form 4 filings
SEC reporting owner CIK 1699022. 11 Form 4 filings on record with FilingPulse; latest filed 2025-07-17.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2025-01-06 to 2025-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 9 filings — 815,151 shares, $4,025,796 total (shares × price as filed on priced legs).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
- Largest priced transaction: sale of 81,891 shares @ $19.19 ($1,571,488) in NewAmsterdam Pharma Co N.V., filed 2025-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | 11 | — | 19 legs · 815,151 sh · $4,025,796 | 33 |
Form 4 filings — Kling Douglas F
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-07-17 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Option exercise (M): 47,569 @ $10.90 · Sale (S): 44,025 @ $21.38 · Sale (S): 3,544 @ $22.12 · Option exercise (M): 51,043 @ $10.90 · Sale (S): 51,043 @ $21.10 · Option exercise (M): 47,569 (derivative) @ $0 · +1 more | EDGAR |
| 2025-06-18 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Option exercise (M): 78,101 @ $10 · Option exercise (M): 21,899 @ $10.90 · Sale (S): 81,891 @ $19.19 · Sale (S): 18,109 @ $19.75 · Option exercise (M): 78,101 (derivative) @ $0 · Option exercise (M): 21,899 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Option exercise (M): 100,000 @ $10 · Sale (S): 100,000 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-04-17 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Option exercise (M): 100,000 @ $10 · Sale (S): 99,090 · Sale (S): 910 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Option exercise (M): 16,539 @ $0 · Sale (S): 16,539 · Grant/award (A): 16,539 (derivative) · Option exercise (M): 16,539 (derivative) | EDGAR |
| 2025-03-19 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Option exercise (M): 88,112 · Option exercise (M): 11,888 @ $10 · Sale (S): 100,000 · Option exercise (M): 88,112 (derivative) @ $0 · Option exercise (M): 11,888 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Option exercise (M): 90,782 · Sale (S): 90,782 · Option exercise (M): 9,218 · Sale (S): 9,218 · Option exercise (M): 90,782 (derivative) @ $0 · Option exercise (M): 9,218 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Option exercise (M): 56,863 · Sale (S): 56,863 · Option exercise (M): 13,578 · Sale (S): 4,664 · Sale (S): 8,914 · Option exercise (M): 56,863 (derivative) @ $0 · +1 more | EDGAR |
| 2025-01-29 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Option exercise (M): 104,174 · Sale (S): 80,359 · Sale (S): 23,815 · Option exercise (M): 25,385 · Sale (S): 20,237 · Sale (S): 5,148 · +2 more | EDGAR |
| 2025-01-07 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/award (A): 44,000 | EDGAR |
| 2025-01-06 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1699022 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →